Background: Merkel cell carcinoma (MCC) is a malignant neuroendocrine neoplasm which shares structural and immunohistochemical features with neuroectodermally derived cells. One hypothesis claims that it arises from Merkel cells, highly innervated neuroendocrine cells involved in mechanoreception in the skin. The incidence rate of this cancer increases with age and sun exposure as well as after immunosuppression. Recently, the clonal integration of a newly identified polyomavirus called Merkel cell polyomavirus (MCPyV) was reported in up to 80% of MCC tissue. Here we report the incidence rate of MCPyV in MCC patients in Switzerland. Methods: We performed polymerase chain reaction in a collection of 32 samples obtained from pathology institutes around Switzerland. We used three different published primer sets. As control groups we used 7 squamous cell carcinoma samples and 11 normal skin samples. Conclusions: We detected viral DNA in 20 out of 30 cases of MCC and in 0 out of 19 control samples. The presence of viral DNA in 66.6% of our MCC tissue specimens confirms the high prevalence of MCPyV in MCC patients described in American, German, French and Hungarian patient collections.

Keywords:
Carcinogenesis, MCPyV, Merkel cell carcinoma, Polyomavirus
1.
Toker C: Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107–110.
2.
Hodgson NC: Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005;89:1–4.
3.
American Cancer Society: Cancer Facts & Figures 2006. http://www.cancer.org/Research/CancerFactsFigures/cancer-facts-figures-2006.
4.
Swann MH, Yoon J: Merkel cell carcinoma. Semin Oncol 2007;34:51–56.
5.
Penn I, First MR: Merkel’s cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999;68:1717–1721.
6.
Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW: Merkel cell carcinoma and HIV infection. Lancet 2002;359:497–498.
7.
Rubel JR, Milford EL, Abdi R: Cutaneous neoplasms in renal transplant recipients. Eur J Dermatol 2002;12:532–535.
8.
Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096–1100.
9.
Acott PD, Hirsch HH: Bk virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007;22:1243–1250.
10.
Caracciolo V, Reiss K, Khalili K, De Falco G, Giordano A: Role of the interaction between large t antigen and rb family members in the oncogenicity of JC virus. Oncogene 2006;25:5294–5301.
11.
Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y: T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008;105:16272–16277.
13.
Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H: Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009;101:938–945.
14.
Lemos B, Nghiem P: Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 2007;127:2100–2103.
15.
Varga E, Kiss M, Szabo K, Kemeny L: Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas. Br J Dermatol 2009;161:930–932.
16.
Foulongne V, Kluger N, Dereure O, Brieu N, Guillot B, Segondy M: Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 2008;14:1491–1493.
17.
Kassem A, Schopflin A, Diaz C, Weyers W, Stickeler E, Werner M, Zur Hausen A: Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the vp1 gene. Cancer Res 2008;68:5009–5013.
18.
Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D: MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 2009;129:248–250.
19.
Duncavage EJ, Zehnbauer BA, Pfeifer JD: Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol 2009;22:516–521.
20.
Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P: Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 2009;129:246–248.
21.
Wetzels CT, Hoefnagel JG, Bakkers JM, Dijkman HB, Blokx WA, Melchers WJ: Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One 2009;4:e4958.
22.
Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, Almeida A, Boitier F, Carlotti A, Couturaud B, Dupin N: Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 2009;218:48–56.
23.
Kassem A, Technau K, Kurz AK, Pantulu D, Loning M, Kayser G, Stickeler E, Weyers W, Diaz C, Werner M, Nashan D, Zur Hausen A: Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 2009;125:356–361.
24.
Andres C, Belloni B, Puchta U, Sander CA, Flaig MJ: Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors. J Cutan Pathol 2009, Epub ahead of print.
25.
Foulongne V, Dereure O, Kluger N, Moles JP, Guillot B, Segondy M: Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 2010;162:59–63.
26.
Dworkin AM, Tseng SY, Allain DC, Iwenofu OH, Peters SB, Toland AE: Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 2009;129:2868–2874.
27.
Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y: Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009;125:1243–1249.
28.
Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y: Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 2009;33:1378–1385.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.